Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy

@inproceedings{Luo2016LongtermCF,
  title={Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy},
  author={Hua-chun Luo and Y. Z. Lei and Hui-hua Cheng and Zhi-chao Fu and Shao-guang Liao and Jing Feng and Qin Yin and Qun-Hua Chen and Gui-shan Lin and Jin-feng Zhu and Jian-feng Xu and Dian Wang},
  booktitle={Medicine},
  year={2016}
}
The aim of our study was to investigate the relationship between cancer-related fatigue and clinical parameters, and the effect factors of fatigue for the prostate cancer patients. Long-term follow-up is performed using the Fatigue Symptom Inventory before treatment (A), at the end of intensity-modulated radiotherapy (B), and 3 months (C), 12 months (D), 24 months (E), 36 months (F), and 48 months (G) after the end of intensity-modulated radiotherapy. Three dimensions of fatigue are assessed… CONTINUE READING
1
Twitter Mention

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-8 OF 8 REFERENCES